Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

1.90
-0.0900-4.52%
Post-market: 1.930.0300+1.58%19:51 EDT
Volume:98.58K
Turnover:190.27K
Market Cap:1.27M
PE:-0.04
High:2.05
Open:1.97
Low:1.90
Close:1.99
Loading ...

Biodexa ADRs Rise After Successful Appeal of Nasdaq Delisting

Dow Jones
·
16 Oct 2024

Biodexa Announces Successful Appeal of Nasdaq Delisting

GlobeNewswire
·
16 Oct 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
14 Oct 2024

Biodexa’s MTX110 Shows Promise in Brain Cancer Study

TIPRANKS
·
04 Oct 2024

Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma

GlobeNewswire
·
04 Oct 2024

Upcoming Stock Splits This Week (September 30 to October 4) – Stay Invested

TipRanks
·
01 Oct 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
26 Sep 2024

Biodexa Pharmaceuticals Reports Promising H1 2024 Results

TIPRANKS
·
26 Sep 2024

Biodexa Pharmaceuticals H1 2024 EPS (0.1p) Vs (3.6)p YoY

Benzinga
·
26 Sep 2024

Interim results for the six months ended June 30, 2024

GlobeNewswire
·
26 Sep 2024

European Equities Traded in the US as American Depositary Receipts Decrease Friday

MT Newswires Live
·
20 Sep 2024

ADR Ratio Change

GlobeNewswire
·
20 Sep 2024

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading

MT Newswires Live
·
18 Sep 2024

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

MT Newswires Live
·
17 Sep 2024

Biodexa Pharmaceuticals Advances FAP Treatment

TIPRANKS
·
16 Sep 2024

Announces Payment of $3.0MM Final Match Payment Enabling Access to Remainder of $17.0MM CPRIT Grant

GlobeNewswire
·
16 Sep 2024